Virtual Reality Augmented Gait Adaptation in Stroke Survivors
Launched by UNIVERSITY OF NEBRASKA · Dec 21, 2018
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how virtual reality (VR) can help stroke survivors improve their walking. After a stroke, many people have difficulty walking evenly, meaning one leg may move differently than the other. The researchers want to see if using VR during walking training can help these individuals better understand and improve their walking patterns. They will invite stroke survivors who have been dealing with this walking issue for at least three months to participate in the study.
To join the trial, participants must be over 21, have had a specific type of stroke, and be able to walk a short distance without help. They should also be able to follow simple instructions. Those who take part can expect to learn new walking tasks in a VR setting and help researchers understand how well they perceive their walking differences. This study is currently looking for participants, and it could be a valuable opportunity for stroke survivors to enhance their mobility and gain insights into their walking abilities.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • adults \> 21 years
- • diagnosed with supratentorial ischemic or hemorrhagic stroke
- • single, unilateral stroke
- • stroke incident \> 3 months duration.
- • ability to stand unsupported without an assistive device
- • walk 10m without therapist assistance,
- • ability to follow instructions (Folstein Mini-Mental exam score ≥ 24)
- Exclusion Criteria:
- • recurrent stroke
- • hip fracture
- • myocardial infarction
- • \< 20/40 corrected vision
- • any condition that can affect walking ability to complete the experiment successfully (e.g. neglect, Parkinson's disease, vestibulopathy, peripheral nerve pathology).
About University Of Nebraska
The University of Nebraska is a leading academic institution dedicated to advancing healthcare through innovative research and clinical trials. With a strong commitment to improving patient outcomes and fostering scientific discovery, the university collaborates with various healthcare professionals and researchers to conduct rigorous clinical studies across diverse medical fields. The institution prioritizes ethical standards and patient safety while striving to translate research findings into practical solutions that enhance medical practices and contribute to the overall well-being of the community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Omaha, Nebraska, United States
Omaha, Nebraska, United States
Patients applied
Trial Officials
Mukul Mukherjee, PhD
Principal Investigator
University of Nebraska
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials